435 Studies Now Enrolling
A Phase 1, Single Dose, Open-label, Safety, Tolerability, and Pharmacokinetic Study of LYN-014 in Individuals with Opioid Use Disorder who are Stable on Methadone Therapy
A Study of LYN-014 in Individuals with Opioid Use Disorder who are Stable on Methadone Therapy
| Sponsor: | Lyndra |
| Enrolling: | Male and Female Patients |
| Study Length: | 45 Days |
| IRB Number: | 8188 |
| U.S. Govt. ID: | NCT05251376 |
| Contact: | Rachel Luba: 646-774-6243 / rachel.luba@nyspi.columbia.edu |
Additional Study Information:
Have an Opioid Use Disorder? We need your help for an inpatient clinical research study! Help the New York State Psychiatric Institute research better treatment options for those with opioid use disorder.You could earn up to $12,017.00.You must meet the following criteria: - Age 18 -59 years old- Have opioid use disorder- Be currently taking an oral daily methadone therapy at a dose of 60-120 mg Call: 646-774-6243 to learn more
This study is closed
